AT362510B - Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formen - Google Patents
Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formenInfo
- Publication number
- AT362510B AT362510B AT767976A AT767976A AT362510B AT 362510 B AT362510 B AT 362510B AT 767976 A AT767976 A AT 767976A AT 767976 A AT767976 A AT 767976A AT 362510 B AT362510 B AT 362510B
- Authority
- AT
- Austria
- Prior art keywords
- dispersions
- peptide
- acid derivatives
- solid solutions
- hydrated forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2546577A DE2546577B2 (de) | 1975-10-17 | 1975-10-17 | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA767976A ATA767976A (de) | 1980-10-15 |
| AT362510B true AT362510B (de) | 1981-05-25 |
Family
ID=5959411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT767976A AT362510B (de) | 1975-10-17 | 1976-10-15 | Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formen |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5854122B2 (nl) |
| AT (1) | AT362510B (nl) |
| AU (1) | AU508628B2 (nl) |
| BE (1) | BE847368A (nl) |
| CA (1) | CA1079641A (nl) |
| CH (1) | CH643737A5 (nl) |
| CS (1) | CS199647B2 (nl) |
| DE (1) | DE2546577B2 (nl) |
| DK (1) | DK146194C (nl) |
| ES (1) | ES452420A1 (nl) |
| FI (1) | FI762875A (nl) |
| FR (1) | FR2327764A1 (nl) |
| GB (1) | GB1560406A (nl) |
| GR (1) | GR61268B (nl) |
| HK (1) | HK3183A (nl) |
| HU (1) | HU172533B (nl) |
| IE (1) | IE43778B1 (nl) |
| IL (1) | IL50686A (nl) |
| MY (1) | MY8400063A (nl) |
| NL (1) | NL184558C (nl) |
| NO (1) | NO144468C (nl) |
| NZ (1) | NZ182341A (nl) |
| PH (1) | PH14513A (nl) |
| PT (1) | PT65719B (nl) |
| SE (1) | SE430379B (nl) |
| SG (1) | SG63082G (nl) |
| SU (1) | SU1165223A3 (nl) |
| ZA (1) | ZA766166B (nl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
| US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
| DK154607C (da) * | 1978-12-21 | 1989-06-05 | Sandoz Ag | Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider |
| FR2454804B1 (fr) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
| ATE72111T1 (de) * | 1987-01-14 | 1992-02-15 | Ciba Geigy Ag | Therapeutisches system fuer schwerloesliche wirkstoffe. |
| FR2610827B1 (fr) * | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
| DE4401646A1 (de) * | 1994-01-21 | 1995-07-27 | Krewel Werke Gmbh | Optimal freisetzende Kava-Extrakte |
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| DE69821984T2 (de) * | 1997-12-22 | 2004-12-30 | Schering Corp. | Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit |
| US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| KR100504618B1 (ko) * | 1999-12-03 | 2005-08-04 | 폴리켐 에스.아. | 향상된 생체 이용율을 갖는 에르고트 알칼로이드의 서방형약제학적 조성물의 제조방법 및 그들의 조성물 |
| US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
| DE60309356T2 (de) * | 2003-06-27 | 2007-08-30 | Bioprogress S.P.A. | Zusammensetzung, durch zusammen vermahlen eines wirkstoffes mit einem n-vinyl-2-pyrrolidon/vinylacetatkopolymers erhältlich |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/de not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/de not_active IP Right Cessation
- 1976-10-08 FI FI762875A patent/FI762875A/fi not_active Application Discontinuation
- 1976-10-08 SE SE7611189A patent/SE430379B/xx not_active IP Right Cessation
- 1976-10-08 NO NO763446A patent/NO144468C/no unknown
- 1976-10-08 DK DK454176A patent/DK146194C/da not_active IP Right Cessation
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/nl not_active IP Right Cessation
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-14 FR FR7630866A patent/FR2327764A1/fr active Granted
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-15 ES ES452420A patent/ES452420A1/es not_active Expired
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/xx unknown
- 1976-10-15 NZ NZ182341A patent/NZ182341A/xx unknown
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/hu not_active IP Right Cessation
- 1976-10-15 AT AT767976A patent/AT362510B/de not_active IP Right Cessation
- 1976-10-15 IL IL50686A patent/IL50686A/xx unknown
- 1976-10-15 CS CS766685A patent/CS199647B2/cs unknown
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 BE BE171578A patent/BE847368A/xx not_active IP Right Cessation
- 1976-10-15 PT PT65719A patent/PT65719B/pt unknown
- 1976-10-15 SU SU762412401A patent/SU1165223A3/ru active
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/ja not_active Expired
- 1976-10-16 GR GR51952A patent/GR61268B/el unknown
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/xx unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT362510B (de) | Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formen | |
| AT340895B (de) | Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen | |
| AT344683B (de) | Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1-aminopropanen und deren saeureadditionssalzen | |
| AT352709B (de) | Verfahren zur herstellung von neuen benzothio- phenderivaten und von deren saeureadditions- salzen | |
| AT358555B (de) | Verfahren zur herstellung von neuen n-amino- alkyl-2-methoxy-benzolsulfonamiden sowie deren saeureadditionssalzen | |
| AT355563B (de) | Verfahren zur herstellung von neuen imidazolyl- oximaethern und von deren saeureadditionssalzen | |
| AT347034B (de) | Verfahren zur herstellung von neuen n- acylamino-alfa-arylacetamido-cephalosporinen sowie von deren salzen | |
| AT340389B (de) | Verfahren zur herstellung von 1-cyanophenoxy-2-hydroxy-3-aminopropanen sowie deren saureadditionssalzen | |
| AT346303B (de) | Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen | |
| AT344726B (de) | Verfahren zur herstellung von neuen 9-substituierten adeninen und deren saeureadditionssalzen | |
| ATA473076A (de) | Verfahren zur herstellung von neuen substituierten 3-aminomethylbenzolsulfonamiden sowie deren saureadditionssalzen | |
| AT340896B (de) | Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| ATA842675A (de) | Verfahren zur herstellung von neuenpyrrolidonderivaten sowie deren salzen | |
| AT338762B (de) | Verfahren zur herstellung von neuen substituierten basischen phenolathern sowie deren saureadditionssalzen | |
| AT340897B (de) | Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| ATA268375A (de) | Verfahren zur herstellung von 1-aryloxy-2-hydroxy-3-beta-(p-aminocarbonylphenyloxy)-athylaminopropanen sowie deren saureadditionssalzen | |
| AT329020B (de) | Verfahren zur herstellung von halogenierten 2-aminobenzylaminen sowie deren saureadditionssalzen | |
| AT342021B (de) | Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| AT340894B (de) | Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen | |
| AT339878B (de) | Verfahren zur herstellung von neuen alfa-tricycloalkylidenarylmethyloxyalkylaminen und deren saureadditonssalzen | |
| ATA502975A (de) | Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen | |
| AT348979B (de) | Verfahren zur herstellung von neuen 7-aminomethylbenzocycloheptenen und deren saeureadditonssalzen | |
| AT327876B (de) | Verfahren zur herstellung von halogenierten 2-amino-benzylaminen sowie deren saureadditionssalzen | |
| ATA696676A (de) | Verfahren zur herstellung von neuen alfa-tricycloheptyliden-arylmethoxyalkylaminen sowie deren saureadditionssalzen | |
| AT353271B (de) | Verfahren zur herstellung von neuen 2- piperidinoalkyl-(1-benzofuranen, 1,4-benzo- dioxanen oder 1,4-benzoxathianen) und deren saeureadditonssalzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |